LEADER 03513nam  2200709 a 450 
001 9910782410703321
005 20230721004048.0
010   $a92-4-068290-2
035   $a(CKB)1000000000689716
035   $a(OCoLC)290609779
035   $a(CaPaEBR)ebrary10227093
035   $a(SSID)ssj0000283353
035   $a(PQKBManifestationID)11251702
035   $a(PQKBTitleCode)TC0000283353
035   $a(PQKBWorkID)10248158
035   $a(PQKB)10808696
035   $a(MiAaPQ)EBC344010
035   $a(Au-PeEL)EBL344010
035   $a(CaPaEBR)ebr10227093
035   $a(OCoLC)476159387
035   $a(EXLCZ)991000000000689716
100   $a20081107d2007      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aRabies and envenomings$b[electronic resource] $ea neglected public health issue : report of a consultative meeting, World Health Organization, Geneva, 10 January 2007 /$f[prepared by D. Warrell and J-M Gutie?rrez]
210   $aGeneva $cWorld Health Organization$d2007
215   $a1 online resource (38 p.) 
300   $a"This Report was developed by compiling the information provided at the WHO Consultative Meeting on Rabies and Envenomings: a Neglected Public Health Issue that took place at WHO, Geneva on 10 January 2007"--T.p. verso.
311   $a92-4-156348-6 
320   $aIncludes bibliographical references.
330   $aThe aim of this consultative meeting was to discuss strategies for improving the quality and quantity of therapeutic antisera, essential drugs for the effective treatment of suspected rabid dog bites and envenoming by snake bites and scorpion stings. Inadequacies in the efficacy, safety and production of these antisera have created a major global public health crisis, especially in Africa and Asia. Each year, millions of people are bitten by dogs or snakes or stung by scorpions and the failure to provide antisera costs at least 150,000 lives and at least as many cases of permanent physical handicap. The solution to this crisis demands an international effort to promote transfer of technology to affected countries, to improve standards through the WHO's prequalification scheme and to facilitate distribution of antisera and training of medical personnel in their optimal use.--Publisher's description.
606   $aRabies$xPatients$xMedical care
606   $aRabies$xEpidemiology
606   $aRabies$xChemotherapy
606   $aBites and stings$xPatients$xMedical care
606   $aBites and stings$xEpidemiology
606   $aBites and stings$xChemotherapy
606   $aImmune serums$xTherapeutic use
606   $aDrug utilization
606   $aPoisonous animals$xVenom$xPhysiological effect
615  0$aRabies$xPatients$xMedical care.
615  0$aRabies$xEpidemiology.
615  0$aRabies$xChemotherapy.
615  0$aBites and stings$xPatients$xMedical care.
615  0$aBites and stings$xEpidemiology.
615  0$aBites and stings$xChemotherapy.
615  0$aImmune serums$xTherapeutic use.
615  0$aDrug utilization.
615  0$aPoisonous animals$xVenom$xPhysiological effect.
700   $aWarrell$b D. A$0283219
701   $aGutie?rrez$b J-M$g(Jose? Mari?a)$01542914
712 02$aWorld Health Organization.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910782410703321
996   $aRabies and envenomings$93796071
997   $aUNINA